Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)

NCT03008031 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03008031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03008031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2017
Completion date
April 30, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, contrast-enhanced spectral mammography